Oncology Nursing Forum - Arsenic trioxide may improve survival from leukemia
May 1, 2007 -- Recent results from a Cancer and Leukemia Group B phase III clinical trial showed that adult patients with acute promyelocytic leukemia (APL) who...
Journal of Drugs in Dermatology - The incidence of recurrent herpes simplex and herpes zoster infection during treatment with arsenic trioxide
February 1, 2006 -- Abstract We report the incidence of varicella zoster virus (VZV) and herpes simplex virus (HSV) infection in patients with multiple myeloma and...
Journal of Research of the National Institute of Standards and Technology - Potassium bromate assay by redox titrimetry using arsenic trioxide
January 1, 2003 -- Bromate, a disinfectant, is one of the analytes of interest in wastewater analysis. Environmental laboratories have a regulatory need for their...
Chain Drug Review - Arsenic Trioxide on fast-track review
April 10, 2000 -- Cell Therapeutics Inc.'s Arsenic Trioxide (ATO) is on fast-track review status with the FDA, which usually shorten the agency's investigation of the...
Alternative Medicine Review - Efficacy and safety results with the combination therapy of arsenic trioxide, dexamethasone, and ascorbic acid in multiple myeloma patients: a phase 2 trial
September 1, 2006 -- Abou-Jawde RM, Reed J, Kelly M. et al. Med Oncol 2006;23:263-272. BACKGROUND: Single-agent arsenic trioxide has shown promising results in patients...
PR Newswire Europe - Arsenic Trioxide and Pixantrone Highlighted in 42 Abstracts and Presentations at The American Society of Hematology Meeting.
November 23, 2004 -- SEATTLE, November 23 /PRNewswire/ -- -Updates on two phase II pixantrone studies demonstrate high rates of complete responses Cell...
PR Newswire Europe - Treatment of Newly Diagnosed Acute Promyelocytic Leukemia With Arsenic Trioxide May Remove Need for Anthracycline Chemotherapy.
October 4, 2004 -- SEATTLE, October 4 /PRNewswire/ -- - Long Lasting Complete Remissions Reported in 88% of Patients An Iranian investigational study of...
Chemical Market Reporter - ARSENIC TRIOXIDE.(by Cell Therapeutics Inc.)(Brief Article)
July 24, 2000 -- Cell Therapeutics Inc. has received orphan drug status for Arsenic TriOxide (ATO), its novel cancer drug treatment, from Food and Drug...
M2 Presswire - FDA approves arsenic trioxide for leukemia treatment in record time for a cancer drug development program.
September 27, 2000 -- M2 PRESSWIRE-27 September 2000-US FDA: FDA approves arsenic trioxide for leukemia treatment in record time for a cancer drug development program...
AFP - Well known as poison, arsenic can prolong life of leukemia patients
June 3, 2007 -- CHICAGO (AFP) — Well known as a poison that can kill, arsenic also can prolong the lives of patients with a rare form of leukemia, a new study...
